This survey study examined associations between demographic and clinical variables and eczema burden in adults. Key findings include identifying factors contributing to eczema severity, which can inform targeted interventions.
A fusion protein composed of scFv and human serum albumin has been developed to target the acetylcholine receptor in myasthenia gravis. The protein showed a high inhibition rate (2.0-77.4%) for binding to acetylcholine receptors, indicating potential therapeutic efficacy.
Researchers from UTHealth and Lund University have discovered a genetic variant in the Factor V gene causing an abnormal form of the protein FV-Short, leading to excessive TFPI formation and uncontrolled bleeding. The study provides insight into the clotting process and offers potential treatment possibilities for the rare condition.
A genetic mutation in coagulation factor 5 is identified as the cause of a severe hereditary bleeding disorder in East Texas. The mutation leads to the production of a truncated form of FV, which forms a complex with tissue factor pathway inhibitor-α that inhibits coagulation pathways.
Research has found an association between marijuana use in young males and the development of cyclic vomiting syndrome (CVS), which shares clinical features with functional vomiting. CVS is more common among young males using marijuana, highlighting the need for further research into treatment options for this condition.